Provisions related to the donation of medical equipment

Pharmaceutical companies and medical and health institutions can sign an agreement in accordance with the provisions. In the donation is not yet common, inexperienced at this stage, pharmaceutical companies and medical and health institutions to non-"isolation zone" way to donate and be donated, the agreement should be fully embodied in the agreement of the agreement should be voluntary and gratuitous and public welfare purposes, pharmaceutical companies and medical and health institutions must pay attention to this, so as not to be suspected of commercial bribery because of the defects of the agreement terms and conditions, and (or) unfair competition. or) unfair competition.

One of the four points of attention in the donation of medical supplies:

1, the recipient unit should be legally compliant;

2, the donation of medical supplies should meet the quality standards;

3, to comply with the donation process;

Two of the donation process:

1, the donor unit of the internal decision-making;

2, recipient Unit pre-assessment;

3, sign the donation agreement;

4, acceptance of donations;

5, information disclosure, supervision and management.

Legal basis: The Chinese People's **** and the State Drug Administration Law Article 107 The State implements a unified system for the publication of drug safety information. The overall situation of national drug safety, drug safety risk warning information, major drug safety incidents and their investigation and handling of information and the State Council to determine the need to unify the publication of other information by the State Council drug supervision and management department to unify the publication. Drug safety risk warning information and major drug safety events and their investigation and handling of the impact of information is limited to a particular region, can also be published by the relevant provinces, autonomous regions and municipalities directly under the Central People's Government Drug Administration. Unauthorized publication of the above information is not allowed.

Publication of drug safety information shall be timely, accurate and comprehensive, with necessary explanations to avoid misleading.

No unit or individual shall fabricate or disseminate false drug safety information.